BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of 206.57 billion as of August 15, 2025. Its market cap has decreased by -31.36% in one year.

Market Cap

206.57B

Enterprise Value

191.08B

Revenue

57.77B

Ranking

n/a

PE Ratio

16.67

Stock Price

1,107.00

Market Cap Chart

Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 4.20B to 206.57B, an increase of 4,813.76%. That is a compound annual growth rate of 16.11%.

Market Cap History

Date	Market Cap	% Change
Aug 14, 2025	209.56B	-19.72%
Dec 31, 2024	261.03B	-14.99%
Dec 29, 2023	307.05B	-18.16%
Dec 30, 2022	375.17B	12.82%
Dec 31, 2021	332.53B	4.98%
Dec 31, 2020	316.75B	10.58%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wal-Mart de México	980.76B
Grupo Financiero Banorte	470.01B
Arca Continental	335.33B
Industrias Peñoles	218.02B
GMéxico Transportes	139.53B
FIBRA Prologis	114.21B
Promotora y Operadora de Infraestructura, S. A. B. de C. V.	100.51B
Fibra UNO	99.01B

Market Cap Rankings